Gastric foveolar-type adenomas endoscopically showing a raspberry-like appearance in the Helicobacter pylori-uninfected stomach

Abstract

Background and study aims Foveolar-type adenoma is described as a very rare tumor that occurs in individuals without Helicobacter pylori (HP) infection and diagnosed as adenocarcinoma in the Japanese Classification of Gastric Carcinoma (JCGC). However, we have frequently encountered patients with foveolar-type adenoma that endoscopically resembles a hyperplastic polyp, suggesting that it has just been overlooked to date. Here, we analyzed clinicopathological characteristics of a special subtype of foveolar-type adenoma showing specific endoscopic findings.

Patients and methods From a total of 212 patients with gastric cancer resected during a 22-month period, we enrolled 14 (6.6 %) diagnosed with foveolar-type adenoma (adenocarcinoma in JCGC). HP infection status was determined by eradication history, HP serum IgG antibody level, urea breath test, and endoscopic and histological findings. All lesions were observed using white-light endoscopy and narrow-band imaging with magnification endoscopy (NBIME). Endoscopically resected lesions were histologically examined.

Results None of 14 patients had a current or past history of HP infection. All lesions were visualized on non-atrophic gastric mucosa as small reddish protrusions with fine granular surface, showing a raspberry-like appearance. NBIME showed papillary or gyrus-like microstructures with irregular capillary. Lesions were histologically diagnosed as foveolar-type adenoma showing MUC5AC-positive gastric mucin phenotype. Ki-67 was overexpressed (median labeling index 69.9 %, range 28.4 – 92.1 %), though all lesions were an intraepithelial tumor without stromal invasion. p53 over-staining was not seen in any.

Conclusions Raspberry-like lesions on non-atrophic gastric mucosa in HP-uninfected individuals should be evaluated for the possibility of a special subtype of foveolar-type adenoma.

• References

• 1 Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-490
• 2 Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353
• 3 Matsuo T, Ito M, Takata S. et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 2001; 16: 415-419
• 4 Ono S, Kato M, Suzuki M. et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological Atrophy. Digestion 2012; 86: 59-65
• 5 Kiso M, Yoshihara M, Ito M. et al. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. Gastric Cancer 2017; 20: 764-771
• 6 Fenoglio-Preiser’s Gastrointestinal Pathology. 4th. Amy EN. (Ed). Wolters Kluwer; 2017
• 7 Park DY, Srivastava A, Kim GH. et al. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. Am J Surg Pathol 2008; 32: 524-533
• 8 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guideline 2010: 3rd English edition. Gastric Cancer 2011; 14: 113-123
• 9 Sekine S, Yoshida H, Jansen M. et al. The Japanese viewpoint on the histopathology of early gastric cancer. Adv Exp Med Biol 2016; 908: 331-346
• 10 Hongo M, Fujimoto K. Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol 2010; 45: 618-624
• 11 Ootani H, Iwakiri R, Shimoda R. et al. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol 2006; 41: 41-46
• 12 Kishikawa H, Kimura K, Takarabe S. et al. Helicobacter pylori antibody titer and gastric cancer screening. Dis Markers 2015; 2015: 156719
• 13 Kimura K, Takemoto T. An endoscopic recognition of atrophic border and significance in chronic gastritis. Endoscopy 1969; 3: 87-97
• 14 Dixon MF, Genta RM, Yardley JH. et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
• 15 Rugge M, Correa P, Dixon MF. et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24: 167-176
• 16 Schlemper RJ, Riddell RH, Kato Y. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
• 17 Lauwers G, Carneiro F, Graham D. et al. WHO classification of tumors of the digestive system. 4th ed. Lyon: JARC; 2010
• 18 Eozoe Y, Muto M, Uedo N. et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 2011; 141: 2017-2025
• 19 Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy 2009; 41: 462-467
• 20 Togo K, Ueo T, Yonemasu H. et al. Two cases of adenocarcinoma occurring in sporadic fundic gland polyps observed by magnifying endoscopy with narrow band imaging. World J Gastroenterol 2016; 22: 9028-9034
• 21 Abraham SC, Nobukawa B, Giardiello FM. et al. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol 2001; 158: 1005-1010
• 22 Saito A, Shimoda T, Nakanishi Y. et al. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 2001; 51: 165-171
• 23 Kabashima A, Yao T, Sugimachi K. et al. Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas. Hum Pathol 2002; 33: 80-86
• 24 Koseki K, Takizawa T, Koike M. et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000; 89: 724-732
• 25 Tajima Y, Yamazaki K, Makino R. et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006; 12: 6469-6479
• 26 Ueyama H, Matsumoto K, Nagahara A. et al. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy 2014; 46: 153-157
• 27 Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer 2017; 20: 3-7
• 28 Horiuchi Y, Fujisaki J, Yamamoto N. et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer 2016; 19: 160-165
• 29 Serra S, Ali R, Bateman AC. et al. Gastric foveolar dysplasia: a survey of reporting habits and diagnostic criteria. Pathology 2017; 49: 391-396
• 30 Luo G, Hu Y, Zhang Z. et al. Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis. Oncotarget 2017; 8: 50273-50283
• 31 Ko GH, Go SI, Lee WS. et al. Prognostic impact of Ki-67 in patients with gastric cancer—the importance of depth of invasion and histologic differentiation. Medicine 2017; 96: e7181
• 32 Maekita T, Nakazawa K, Mihara M. et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12: 989-995
• 33 Niwa T, Tsukamoto T, Toyoda T. et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010; 70: 1430-1440
• 34 Hansford S, Kaurah P, Li-Chang H. et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol 2015; 1: 23-32
• 35 Wei J, Nagy TA, Vilgelm A. et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology 2010; 139: 1333-1343